Lambdalina (Lidocaine)

Lidocaine works by blocking voltage‑gated sodium channels on nerve cells. This inhibition prevents the rapid influx of sodium ions needed for depolarisation, stopping the generation and transmission of pain signals and resulting in a temporary loss of sensation in the treated area.

The appropriate amount of Lambdalina is determined by the prescribing healthcare professional based on the size of the area to be treated, the specific indication, and patient factors. Patients should follow the prescriber’s instructions and not exceed the recommended application amount.

Safety data for topical lidocaine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and under the guidance of a qualified healthcare provider.

To order Lambdalina, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lambdalina’s lidocaine formulation offers rapid onset and a well‑characterised safety profile compared with alternatives such as benzocaine or prilocaine. While all provide surface anaesthesia, lidocaine generally has a lower incidence of allergic reactions and is widely accepted for a broad range of minor procedures.

Lambdalina should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and sources of heat. Ensure the container is tightly closed when not in use to maintain product integrity.

Lambdalina is applied topically to clean, dry skin. A thin layer is spread over the intended area, avoiding excessive amounts. The medication is left in place for the duration recommended by the prescriber, after which it can be gently removed or left to absorb, depending on the clinical need.

Serious risks include systemic toxicity if large skin areas are treated, which can manifest as central nervous system effects such as seizures, or cardiac disturbances. Rarely, allergic reactions such as dermatitis or anaphylaxis may occur. Immediate medical attention is required if systemic symptoms develop.

Individuals with a known hypersensitivity to lidocaine, other amide‑type local anesthetics, or any component of the formulation should avoid using Lambdalina. It is also contraindicated on severely damaged or infected skin unless directed by a healthcare professional.